Introducing CentaurAI: AI-Accelerated Regulatory Submissions
CentaurAI™ combines advanced AI drafting with DHCG’s deep regulatory expertise to deliver faster, higher-quality IND authorship
LEARN MORE
In-house IND authorship pulls development teams away from activities supporting asset development and preparation for clinical trials
Manually collating source materials, validating data quality, and module authoring, often result in a months long process - putting your critical path at your risk
Top-quality regulatory submissions that avoid the risk of clinical hold or receiving information requests require highly experienced ex-FDA regulatory expertise, which is often unavailable in-house or in other 3rd party reviewers
CentaurAI™ merges the speed of large language models with the uncompromising quality standards of Dark Horse Consulting.
CentaurAI efficiently compiles and processes source files to rapidly generate your IND, drastically reducing timelines to submission
IND quality is fully validated by DHCG’s world class regulatory team whose track record includes 120+ regulatory submissions across novel biotherapeutic modalities
A seamless integration of AI precision and expert human oversight
with privacy and security built in throughout.
Confidentiality Commitment: DHC treats all client data as strictly confidential. Your information will not be shared, sold, or disclosed to third parties unless we have received your express written consent or are required to do so by applicable law.